Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human in vivo metabolism study of LGD‐4033
Argyro G. Fragkaki, P. Sakellariou, Polyxeni Kiousi, et al.
Drug Testing and Analysis (2018) Vol. 10, Iss. 11-12, pp. 1635-1645
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Selective androgen receptor modulators: the future of androgen therapy?
Andrew R. Christiansen, Larry I. Lipshultz, James M. Hotaling, et al.
Translational Andrology and Urology (2020) Vol. 9, Iss. S2, pp. S135-S148
Open Access | Times Cited: 93
Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users
Jonathan D. Vignali, Kevin Pak, Holly Beverley, et al.
Journal of Xenobiotics (2023) Vol. 13, Iss. 2, pp. 218-236
Open Access | Times Cited: 25
Analytical Approaches in Human Sports Drug Testing: Recent Advances, Challenges, and Solutions
Mario Thevis, Katja Walpurgis, Andreas Thomas
Analytical Chemistry (2019) Vol. 92, Iss. 1, pp. 506-523
Closed Access | Times Cited: 49
The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete
Pascal Kintz
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 207, pp. 114433-114433
Open Access | Times Cited: 34
Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review
Steven B. Machek, Thomas D. Cardaci, Dylan T. Wilburn, et al.
Steroids (2020) Vol. 164, pp. 108753-108753
Closed Access | Times Cited: 33
Medicinal Use of Testosterone and Related Steroids Revisited
Jan Tauchen, Michal Jurášek, Lukáš Huml, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1032-1032
Open Access | Times Cited: 30
Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review
T. Köller, Petra Vrbová, Iveta Mečiarová, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 16, pp. 4062-4071
Open Access | Times Cited: 29
Investigation of the metabolism of the selective androgen receptor modulator LGD‐4033 in equine urine, plasma and hair following oral administration
Charlotte Cutler, Marjaana Viljanto, Pamela Hincks, et al.
Drug Testing and Analysis (2019) Vol. 12, Iss. 2, pp. 247-260
Closed Access | Times Cited: 32
Annual banned‐substance review – Analytical approaches in human sports drug testing
Mario Thevis, Tiia Kuuranne, Hans Geyer
Drug Testing and Analysis (2019) Vol. 12, Iss. 1, pp. 7-26
Open Access | Times Cited: 30
Detection of LGD‐4033 Metabolites in Camel Urine, Plasma, and Hair Following Oral Administration for Doping Control
Praseen Ondern Komathu, Syed Ali M Padusha, Laya Saraswathy, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 8
Closed Access
Development and validation of a semi-quantitative ultra-high performance liquid chromatography-tandem mass spectrometry method for screening of selective androgen receptor modulators in urine
Emiliano Ventura, Anna Gadaj, Gail Monteith, et al.
Journal of Chromatography A (2019) Vol. 1600, pp. 183-196
Open Access | Times Cited: 28
LGD-4033, S-4 and MK-2866 – Testing for SARMs in hair: About 2 doping cases
Pascal Kintz, Alice Ameline, Laurie Gheddar, et al.
Annales de Toxicologie Analytique (2018) Vol. 31, Iss. 1, pp. 56-63
Closed Access | Times Cited: 24
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes
Felicitas Wagener, Sven Guddat, Christian Görgens, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 414, Iss. 2, pp. 1151-1162
Open Access | Times Cited: 20
Mass spectrometry in sports drug testing—Analytical approaches and the athletes' exposome
Mario Thevis, Christian Görgens, Sven Guddat, et al.
Scandinavian Journal of Medicine and Science in Sports (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 14
Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing
Mario Thevis, Thomas Piper, Andreas Thomas
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 205, pp. 114312-114312
Closed Access | Times Cited: 18
Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics
Dorota Kwiatkowska, Mariola Wicka, Krzysztof Grucza, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6486-6486
Open Access | Times Cited: 7
High‐throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction
Tim Sobolevsky, Brian Ahrens
Drug Testing and Analysis (2020) Vol. 13, Iss. 2, pp. 283-298
Closed Access | Times Cited: 18
Detection of the selective androgen receptor modulator GSK2881078 and metabolites in urine and hair after single oral administration
Alina Rading, Patricia Anielski, Detlef Thieme, et al.
Drug Testing and Analysis (2020) Vol. 13, Iss. 1, pp. 217-222
Open Access | Times Cited: 17
Simultaneous detection of different chemical classes of selective androgen receptor modulators in urine by liquid chromatography-mass spectrometry-based techniques
Carlotta Stacchini, Francesco Botrè, Fabio Comunità, et al.
Journal of Pharmaceutical and Biomedical Analysis (2020) Vol. 195, pp. 113849-113849
Closed Access | Times Cited: 17
Targeted Metabolic Investigation of Ligandrol and Analytical Methods Validation for Its Main Long‐term Metabolite
Yiannis S. Angelis, Panagiotis Sakellariou, Michael Petrou, et al.
ChemPlusChem (2024) Vol. 89, Iss. 5
Open Access | Times Cited: 2
Advances in SARMs anti‐doping analysis
K Slíz, Peter Mikuš
Drug Testing and Analysis (2024)
Closed Access | Times Cited: 2
Investigation of in vitro generated metabolites of LGD‐4033, a selective androgen receptor modulator, in homogenized camel liver for anti‐doping applications
Praseen Ondern Komathu, M. Syed Ali Padusha, Saraswathy Laya, et al.
Rapid Communications in Mass Spectrometry (2023) Vol. 37, Iss. 22
Open Access | Times Cited: 5
Identification of equine in vitro metabolites of seven non‐steroidal selective androgen receptor modulators for doping control purposes
Charlotte Cutler, Marjaana Viljanto, Polly Taylor, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 2, pp. 349-370
Open Access | Times Cited: 12
Therapeutic effects of androgens for cachexia
Luca Giovanelli, Richard Quinton
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 36, Iss. 5, pp. 101598-101598
Closed Access | Times Cited: 10
Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry
Johanna Breuer, Andreas Thomas, Philippe Delahaut, et al.
Analytical and Bioanalytical Chemistry (2022) Vol. 415, Iss. 4, pp. 669-681
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top